loading...| Preferred Name |
Tigecycline |
|
| Synonyms |
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- |
|
| Definitions |
A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000078304 |
|
| altLabel |
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- GAR 936 GAR936 GAR-936 Tygacil 9-(tert-Butylglycylamido)minocycline TBG-MINO |
|
| AQL |
AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C1615061 C1260298 C1614700 |
|
| DC |
1 |
|
| definition |
A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia. |
|
| DX |
20190101 |
|
| HN |
2019 (1999) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
70JE2N95KR 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
2019; TIGECYCLINE was indexed under MINOCYCLINE/analogs & derivatives 1999-2018 |
|
| MDA |
20180709 |
|
| MMR |
20180619 |
|
| MN |
D04.615.562.900.937 D02.455.426.559.847.562.900.937 |
|
| notation |
D000078304 |
|
| PA |
D011500 D000900 |
|
| prefLabel |
Tigecycline |
|
| TERMUI |
T335013 T335012 T000942170 T653327 T000942171 T335014 |
|
| TH |
NLM (1999) NLM (2005) USAN (19XX) INN (19XX) NLM (2003) FDA SRS (2015) |
|
| tui |
T109 T195 |
|
| subClassOf |